SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000905718-17-000990
Filing Date
2017-11-20
Accepted
2017-11-20 17:15:11
Documents
1
Group Members
PARK WEST INVESTORS MASTER FUND, LTDPETER S. PARK

Document Format Files

Seq Description Document Type Size
1 PLXPHARMA INC. 13D plxpharma13d_nov202017.htm SC 13D 95973
  Complete submission text file 0000905718-17-000990.txt   97773
Mailing Address 900 LARKSPUR LANDING CIRCLE, SUITE 165 LARKSPUR CA 94939
Business Address 900 LARKSPUR LANDING CIRCLE, SUITE 165 LARKSPUR CA 94939 (415) 524-2902
Park West Asset Management LLC (Filed by) CIK: 0001386928 (see all company filings)

IRS No.: 300132084 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Subject) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88072 | Film No.: 171214591
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1